Sir, – As healthcare professionals specialising in addiction, we strongly believe that it is time for Pregabalin to be classified as a controlled drug in Ireland (“‘Coffin tablet’ misuse: Why the painkiller Pregabalin must be made a controlled drug in Ireland”, Health+Family, April 18th).
Pregabalin is a prescription medication that is used to treat nerve pain, anxiety and seizures. However in recent years it has been increasingly misused and abused as a recreational drug. Pregabalin works by increasing the levels of a neurotransmitter called GABA, which produces a feeling of relaxation and euphoria. Unfortunately this has led to its abuse by individuals seeking to achieve a high, especially when combined with other drugs such as opioids, benzodiazepines and alcohol.
The misuse of Pregabalin can have serious consequences, including overdose and death. It has been shown to be highly addictive, leading to physical and psychological dependence. Its withdrawal symptoms can be severe and potentially life-threatening.
We are deeply concerned about the growing misuse of Pregabalin and the harm it is causing. It is vital that we take action to address this problem, and one effective way to do this is by classifying Pregabalin as a controlled drug.
This would mean that the prescribing of Pregabalin would be subject to stricter controls, such as limitation of the quantity prescribed and increased monitoring of its use. This would help to prevent its misuse and diversion while ensuring that those who genuinely need and benefit from the medication can continue to access it.
In conclusion, we urge the authorities in Ireland to take action to classify Pregabalin as a controlled drug. This is an important step in addressing the harm caused by its misuse, and in protecting public health. – Yours, etc,
Dr ENDA BARRON MICGP,
Dr SINEAD FAHY MICGP,
Dr JENNIFER
FitzPATRICK MICGP,
Dr SINEAD
HOWLEY MICGP,
ROUWAYDA
HUSSEIN MPSI,
Dr ROBERT
McGARRIGLE MICGP,
Dr JOSEPH
MOLONY MICGP,
GERALDINE
O’DUBHGHAILL RGN, RSCN,
Dr COLM QUINN GPSSA,
Dr ANGELA
SKUCE MICGP,
Dublin.